Results 141 to 150 of about 5,401 (177)

Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System. [PDF]

Pharmaceuticals (Basel)
Yajima A, Uesawa Y.
europepmc   +1 more source

Real-world management and long-term outcomes in adolescent, young adult, and adult medulloblastoma: Experience from a monocentric series with multimodal and targeted approaches. [PDF]

Neurooncol Pract
Bosio A, Maccari M, Padovan M, Caccese M, Bolshinsky M, Galiano A, Cavallin F, Bellu L, Pasqualetti F, Parisi A, Librizzi G, Pintacuda G, Salvalaggio A, Zoccarato M, Ius T, Volpin F, Denaro L, Lonardi S, Lombardi G.   +18 more
europepmc   +1 more source

Temperature dependent luminescence of europium/cyanine FRET pairs. [PDF]

Chem Sci
Cheung TL, Parker D.
europepmc   +1 more source

Variance in state Medicaid coverage of hedgehog pathway inhibitors in the treatment of basal cell carcinoma. [PDF]

Proc (Bayl Univ Med Cent)
Arora N, Skaggs E, Bicknell L.
europepmc   +1 more source

A rare case of metastatic super giant basal cell carcinoma of the thoracoabdominal wall. [PDF]

JAAD Case Rep
Lee DE, Wynne MD, Collier NJ, Jamieson LA, Cummins DM.   +4 more
europepmc   +1 more source

Eight-Year Experience of Hedgehog Pathway Inhibitors at Three Tertiary Referral Centres in the Australian State of Victoria. [PDF]

Australas J Dermatol
Gan C, Manuelpillai N, Foley P, McCormack C, Goh MS.   +4 more
europepmc   +1 more source

Solasodine inhibited the proliferation of gastric cancer cells through suppression of Hedgehog/Gli1 signaling. [PDF]

Food Sci Biotechnol
Zhou Y, Kim JT, Zhan X, Ghimire A, Lee KH, Son HM, Lee HJ.   +6 more
europepmc   +1 more source

Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors. [PDF]

Int J Mol Sci
Papaccio F, Kovacs D, Marrapodi R, Caputo S, Migliano E, Melucci E, Scalera S, Cota C, Maugeri-Saccà M, Bellei B.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vismodegib

Annals of Pharmacotherapy, 2014
Vismodegib (GDC-0449, Erivedge®) is a novel small molecule antagonist of the hedgehog (Hh) pathway that binds to smoothened (SMO) and leads to inhibition of an aberrant activation of the Hh pathway. Dysregulated Hh signaling results in uncontrolled proliferation in basal cell carcinoma (BCC) and has also been found present in medulloblastoma, and many ...
Lisa A Thompson
exaly   +5 more sources

Vismodegib

Reactions Weekly, 2017
By definition, a drug is a medicine or substance that exerts a physiologic effect on an organism. In dermatology, medications and substances are utilized on a daily basis from topical treatments to anesthetics in surgery.
Siddiqui, Fariha, Fariha Siddiqui, Zito, Patrick M., Patrick M. Zito   +3 more
core   +5 more sources